Lupardo, Gunther, Lunsford, Jacobson, De Los Santos, Curran, McDonald, Fahy
MLTSPNSR
Amd Part C §8, Chap 57 of 2022; amd §5, Chap 21 of 2011
Extends provisions of law relating to allowing pharmacists to direct limited service laboratories and order and administer COVID-19 and influenza tests and modernizing nurse practitioners and authorizing pharmacists to perform collaborative drug therapy management with physicians in certain settings.
NEW YORK STATE ASSEMBLY MEMORANDUM IN SUPPORT OF LEGISLATION submitted in accordance with Assembly Rule III, Sec 1(f)
BILL NUMBER: A8619B
SPONSOR: Paulin TITLE OF BILL:
An act to amend part C of chapter 57 of the laws of 2022 amending the
public health law and the education law relating to allowing pharmacists
to direct limited service laboratories and order and administer COVID-19
and influenza tests and modernizing nurse practitioners, in relation to
the effectiveness thereof; and to amend chapter 21 of the laws of 2011
amending the education law relating to authorizing pharmacists to
perform collaborative drug therapy management with physicians in certain
settings, in relation to the effectiveness thereof
PURPOSE:
To extend the provisions of law that: authorize pharmacists to direct
limited service laboratories and order and administer COVID-19 and
influenza tests; exempt certain nurse practitioners from written prac-
tice agreement and written practice protocol requirements; authorize
physicians and nurse practitioners to prescribe and order a non-patient
specific regimen to registered professional nurses for the adminis-
tration of COVID 19 and influenza tests; and authorize pharmacists to
perform collaborative drug therapy management with physicians in certain
settings.
SUMMARY OF PROVISIONS:
This bill extends, through July 1, 2026, the provisions of law that:
authorize pharmacists to direct limited service laboratories and order
and administer COVID-19 and influenza tests; exempt certain nurse prac-
titioners from written practice agreement and written practice protocol
requirements; authorize physicians and nurse practitioners to prescribe
and order a non-patient specific regimen to registered professional
nurses for the administration of COVID 19 and influenza tests; and
authorize pharmacists to perform collaborative drug therapy management
with physicians in certain settings.
JUSTIFICATION:
This legislation ensures that pharmacists, registered professional nurs-
es, and nurse practitioners can continue providing certain healthcare
services without disruption.
LEGISLATIVE HISTORY:
This is new legislation.
FISCAL IMPLICATIONS:
To be determined.
EFFECTIVE DATE:
Immediate.
STATE OF NEW YORK
________________________________________________________________________
8619--B
IN ASSEMBLY
January 12, 2024
___________
Introduced by M. of A. PAULIN, LUPARDO, GUNTHER, LUNSFORD, JACOBSON,
DE LOS SANTOS, CURRAN -- read once and referred to the Committee on
Higher Education -- committee discharged, bill amended, ordered
reprinted as amended and recommitted to said committee -- again
reported from said committee with amendments, ordered reprinted as
amended and recommitted to said committee
AN ACT to amend part C of chapter 57 of the laws of 2022 amending the
public health law and the education law relating to allowing pharma-
cists to direct limited service laboratories and order and administer
COVID-19 and influenza tests and modernizing nurse practitioners, in
relation to the effectiveness thereof; and to amend chapter 21 of the
laws of 2011 amending the education law relating to authorizing phar-
macists to perform collaborative drug therapy management with physi-
cians in certain settings, in relation to the effectiveness thereof
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Section 8 of part C of chapter 57 of the laws of 2022
2 amending the public health law and the education law relating to allow-
3 ing pharmacists to direct limited service laboratories and order and
4 administer COVID-19 and influenza tests and modernizing nurse practi-
5 tioners, is amended to read as follows:
6 § 8. This act shall take effect immediately and shall be deemed to
7 have been in full force and effect on and after April 1, 2022; provided,
8 however, that sections one, two, three, four, six and seven of this act
9 shall expire and be deemed repealed [two years after it shall have
10 become a law] July 1, 2026.
11 § 2. Section 5 of chapter 21 of the laws of 2011 amending the educa-
12 tion law relating to authorizing pharmacists to perform collaborative
13 drug therapy management with physicians in certain settings, as amended
14 by section 5 of part CC of chapter 57 of the laws of 2022, is amended to
15 read as follows:
16 § 5. This act shall take effect on the one hundred twentieth day after
17 it shall have become a law, provided, however, that the provisions of
18 sections two, three, and four of this act shall expire and be deemed
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD13961-03-4
A. 8619--B 2
1 repealed July 1, [2024] 2026; provided, however, that the amendments to
2 subdivision 1 of section 6801 of the education law made by section one
3 of this act shall be subject to the expiration and reversion of such
4 subdivision pursuant to section 8 of chapter 563 of the laws of 2008,
5 when upon such date the provisions of section one-a of this act shall
6 take effect; provided, further, that effective immediately, the addi-
7 tion, amendment and/or repeal of any rule or regulation necessary for
8 the implementation of this act on its effective date are authorized and
9 directed to be made and completed on or before such effective date.
10 § 3. This act shall take effect immediately.
